Antiarrhythmic effect of atorvastatin on autoimmune myocarditis is mediated by improving myocardial repolarization

Area of Science:

• Cardiology
• Immunology
• Pharmacology

Background:

• Myocarditis involves inflammation and oxidative stress, impacting cardiac function.
• HMG-CoA reductase inhibitors (statins) are known for anti-inflammatory and antioxidant properties.

Purpose of the Study:

• To investigate the effects of atorvastatin on inflammatory progression in experimental autoimmune myocarditis (EAM).
• To assess atorvastatin's impact on cardiac electrophysiological changes, specifically action potential duration (APD) and ion channel currents in ventricular myocytes.

Main Methods:

• Utilized an animal model of EAM in BALB/c mice.
• Administered atorvastatin and evaluated inflammatory markers (TNF-alpha, IFN-gamma).
• Performed whole-cell patch-clamp experiments to measure ventricular cardiomyocyte APD and potassium currents.

Main Results:

• Atorvastatin treatment attenuated inflammatory infiltration and reduced TNF-alpha and IFN-gamma levels in EAM hearts.
• Ventricular cardiomyocyte APD, prolonged in EAM, was normalized by atorvastatin.
• Atorvastatin mitigated the decrease in outward potassium currents observed in EAM myocytes.

Conclusions:

• Atorvastatin ameliorates EAM progression by suppressing inflammatory cytokine levels.
• The drug exhibits antiarrhythmic effects by modulating cardiomyocyte ion channel activity, thereby improving myocardial repolarization.